HCA Healthcare Inc. (NYSE:HCA) remained unchanged to close Tuesday at $274.83 after adding $0.01 on the day. The 5-day average trading volume is 1,171,260 shares of the company’s common stock. It has gained $277.66 in the past week and touched a new high 3 times within the past 5 days. An average of 1,309,020 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,361,580.
HCA’s 1-month performance is -3.63% or -$10.31 on its low of $264.30 reached on 08/18/23. The company’s shares have touched a 52-week low of $178.32 and high of $304.86, with the stock’s rally to the 52-week high happening on 06/30/23. YTD, HCA has achieved 14.53% or $34.87 and has reached a new high 21 times. However, the current price is down -9.85% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
HCA stock investors last saw insider trading activity on Aug 14.Torres Kathryn A. (SVP-Payer Contracting & Align.) most recently sold 5,204 shares at $269.12 per share on Aug 14. This transaction cost the insider $1,400,516. SVP-Government Relations, Cohen Jeffrey E., sold 1,500 shares at a price of $270.00 on Aug 11. Then, on Aug 03, SVP & Chief Ethics Officer Whalen Kathleen M sold 2,916 shares at a price of $270.00 per share. This transaction amounted to $787,320.
Valuation Metrics
HCA stock has a beta of 1.60. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.19 while the price to cash flow ratio at 14.96.
HCA Healthcare Inc.’s quick ratio for the period ended June 29 was 1.00, with the current ratio over the same period at 1.20.. In terms of profitability, the gross margin trailing 12 months is 84.40%. The trailing 12-month EBITDA margin is 19.96% while for the period ending June 29, HCA Healthcare Inc.’s operating margin was 15.00%. The firm’s gross profit as reported stood at $50.86 billion against revenue of $60.23 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 3.19% to $1.19 billion, while revenue of $1.36 billion was -14.25% off the previous quarter. Analysts expected HCA to announce $4.22 per share in earnings in its latest quarter, but it posted $4.29, representing a 1.70% surprise. EBITDA for the quarter stood at more than $3.06 billion. HCA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 53.13 billion, with total debt at $40.74 billion. Shareholders hold equity totaling $271.99 million.
Let’s look briefly at HCA Healthcare Inc. (HCA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 56.73% to suggest the stock is trending Neutral, with historical volatility in this time period at 14.03%.
The stock’s 5-day moving average is $270.27, reflecting a +2.25% or $6.06 change from its current price. HCA is currently trading -3.75% above its 20-day SMA, +6.79% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +1.12% and SMA200 by+28.53%.
Stochastic %K and %D was 68.57% and 43.97% and the average true range (ATR) pointed at 5.01. The RSI (14) points at 50.00%, while the 14-day stochastic is at 78.82% with the period’s ATR at 5.21. The stock’s 9-day MACD Oscillator is pointing at 3.05 and 3.23 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for HCA Healthcare Inc. (NYSE: HCA), Cantor Fitzgerald launched coverage with an Overweight rating. Analysts offering their rating for HCA stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HCA as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 3 rates the stock as overweight while 16 have offered a “buy” rating.
What is HCA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $275.00 and a high of $350.00, with their median price target at $324.00. Looking at these predictions, the average price target given by analysts is for HCA Healthcare Inc. (HCA) stock is $321.48.
